Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
N2AB192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
N2A192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
N2B192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
Novex-1192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
Novex-2192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129
Novex-3192799;800;801 chr2:178800404;178800403;178800402chr2:179665131;179665130;179665129

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-2
  • Domain position: 89
  • Structural Position: 175
  • Q(SASA): 0.4143
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/M None None 0.343 N 0.609 0.186 0.689481310135 gnomAD-4.0.0 6.84072E-07 None None None -0.43(TCAP) N None 0 0 None 0 0 None 0 0 8.99306E-07 0 0
L/R rs1375853157 None 0.779 N 0.729 0.408 0.782842511238 gnomAD-3.1.2 6.57E-06 None None None -0.603(TCAP) N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
L/R rs1375853157 None 0.779 N 0.729 0.408 0.782842511238 gnomAD-4.0.0 2.56104E-06 None None None -0.603(TCAP) N None 0 0 None 0 0 None 0 0 4.7835E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.354 ambiguous 0.4739 ambiguous -1.362 Destabilizing 0.452 N 0.561 neutral None None None -0.375(TCAP) N
L/C 0.8245 likely_pathogenic 0.8691 pathogenic -0.93 Destabilizing 0.978 D 0.647 neutral None None None -0.412(TCAP) N
L/D 0.827 likely_pathogenic 0.8881 pathogenic -0.519 Destabilizing 0.853 D 0.746 deleterious None None None -0.39(TCAP) N
L/E 0.457 ambiguous 0.5543 ambiguous -0.543 Destabilizing 0.81 D 0.753 deleterious None None None -0.508(TCAP) N
L/F 0.2392 likely_benign 0.3346 benign -0.977 Destabilizing 0.697 D 0.605 neutral None None None -0.206(TCAP) N
L/G 0.8117 likely_pathogenic 0.8931 pathogenic -1.643 Destabilizing 0.853 D 0.729 prob.delet. None None None -0.311(TCAP) N
L/H 0.3112 likely_benign 0.4368 ambiguous -0.8 Destabilizing 0.982 D 0.732 prob.delet. None None None 0.302(TCAP) N
L/I 0.1145 likely_benign 0.1369 benign -0.689 Destabilizing 0.008 N 0.467 neutral None None None -0.599(TCAP) N
L/K 0.3094 likely_benign 0.3917 ambiguous -0.782 Destabilizing 0.146 N 0.715 prob.delet. None None None -0.627(TCAP) N
L/M 0.1689 likely_benign 0.2051 benign -0.58 Destabilizing 0.343 N 0.609 neutral N 0.49887892 None -0.43(TCAP) N
L/N 0.5519 ambiguous 0.6711 pathogenic -0.583 Destabilizing 0.853 D 0.751 deleterious None None None -0.494(TCAP) N
L/P 0.9625 likely_pathogenic 0.9831 pathogenic -0.88 Destabilizing 0.899 D 0.753 deleterious D 0.568686662 None -0.52(TCAP) N
L/Q 0.1816 likely_benign 0.2609 benign -0.789 Destabilizing 0.786 D 0.727 prob.delet. N 0.464170041 None -0.49(TCAP) N
L/R 0.2255 likely_benign 0.3111 benign -0.212 Destabilizing 0.779 D 0.729 prob.delet. N 0.470216411 None -0.603(TCAP) N
L/S 0.4268 ambiguous 0.5866 pathogenic -1.231 Destabilizing 0.743 D 0.624 neutral None None None -0.186(TCAP) N
L/T 0.2438 likely_benign 0.3371 benign -1.139 Destabilizing 0.015 N 0.381 neutral None None None -0.3(TCAP) N
L/V 0.108 likely_benign 0.1248 benign -0.88 Destabilizing None N 0.319 neutral N 0.46687838 None -0.52(TCAP) N
L/W 0.4533 ambiguous 0.5782 pathogenic -0.975 Destabilizing 0.995 D 0.74 deleterious None None None -0.334(TCAP) N
L/Y 0.528 ambiguous 0.6564 pathogenic -0.749 Destabilizing 0.354 N 0.68 prob.neutral None None None -0.245(TCAP) N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.